Objective: To compare the values of exophthalmos measured by computed tomography (CT) and Hertel exophthalmometry (HE) in patients with thyroid-associated ophthalmopathy (TAO). Material and Methods: One hundred and seventy eyes were examined in 85 patients with TAO. Each patient underwent a complete ophthalmic examination, Hertel exophthalmometry, and CT of the orbits through a 16-slice CT scanner (Bright Speed, General Electric), measuring the extraocular muscles, the total muscle thickness sum (MTS), and proptosis. The patients were divided into two groups-with activity and without TAO activity, the activity being assessed by means of the Clinical Activity Score (CAS) and the severity-according to the EUGOGO classification. Results: TAO activity was detected in 45 patients (90 eyes, 53%) with MTS of 23.54 ± 5.73 mm, IOP of 19.78 ± 4.49 mm Hg, Hertel exophthalmos of 23.08 ± 4.19 mm and measured by CT-23.32 ± 4.33 mm. Forty patients (80 eyes, 47%) were without TAO activity, with MTS of 19.28 ± 4.03, IOP of 16.6 ± 4.51 mm Hg, Hertel exophthalmos of 20.03 ± 3.84 mm and measured by CT-19.84 ± 4.47 mm. A correlation was detected between exophthalmos and: MTS, IOP, the activity and severity of TАО. High congruence was established between the two methods of measuring exophthalmos-CT and HE (Pearson correlation, r = 0.690, p = 0.000). Conclusion: Our results showed a high degree of consistency between Hertel exophthalmometry and multidetector CT for the evaluation of exophthalmos in patients with TAO. Exophthalmos is an important clinical feature and its measurement and monitoring over time assess the clinical course and outcome of treatment.
References
[1]
Petunina, N.A., Trukhina, L.V. and Martirosyan, N.S. (2012) Endocrine Ophthalmopathy-State-of-the-Art Approaches. Problems of Endocrinology, 58, 24-30. https://doi.org/10.14341/probl201258624-32
[2]
Mourits, M.P., Prummel, M.F., Wiersinga, W.M. and Koornneef, L. (1989) Clinical Activity Score as a Guide in the Management of Patients with Graves’ Ophthalmopathy: A Novel Approach. British Journal of Ophthalmology, 73, 639-644. https://doi.org/10.1136/bjo.73.8.639
[3]
Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., et al. (2008) Consensus Statement of the European Group on Graves’ Orbitopathy (EUGOGO) on Management of GO. European Journal of Endocrinology, 158, 273-285. https://doi.org/10.1530/EJE-07-0666
[4]
Đorić, I., Žarković, M., Radojičić, Z., Repac, N., Janićijević, A., Rotim, K., et al. (2017) The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry. Acta Clinica Croatica, 56, 21-27. https://doi.org/10.20471/acc.2017.56.01.04
[5]
Li, Q., Ye, H., Ding, Y., Chen, G., Liu, Z., Xu, J., et al. (2017) Clinical Characteristics of Moderate-to-Severe Thyroid Associated Ophthalmopathy in 354 Chinese Cases. PLoS ONE, 12, e0176064. https://doi.org/10.1371/journal.pone.0176064
[6]
Strianese, D., Piscopo, R., Elefante, A., Napoli, M., Comune, C., Baronissi, I., et al. (2013) Unilateral Proptosis in Thyroid Eye Disease with Subsequent Contralateral Involvement: Retrospective Follow-Up Study. MBC Ophthalmology, 13, 21. https://doi.org/10.1186/1471-2415-13-21
[7]
Nishida, Y., Tian, S., Isberg, B., Hayashi, O., Tallstedt, L. and Lennerstrand, G. (2002) Significance of Orbital Fatty Tissue for Exophthalmos in Thyroid-Associated Ophthalmopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 240, 515-520. https://doi.org/10.1007/s00417-002-0498-3
[8]
Fang, Z.J., Zhang, J.Y. and He, W.M. (2013) CT Features of Exophthalmos in Chinese Subjects with Thyroid-Associated Ophthalmopathy. International Journal of Ophthalmology, 6, 146-149.
[9]
Vardizer, Y., Berendschot, T.T. and Mourits, M.P. (2005) Effect of Exophthalmometer Design on Its Accuracy. Ophthalmic Plastic and Reconstructive Surgery, 21, 427-430. https://doi.org/10.1097/01.iop.0000180066.87572.39
[10]
Lam, A.K., Lam, C.F., Leung, W.K. and Hung, P.K. (2009) Intra-Observer and Inter-Observer Variation of Hertel Exophthalmometry. Ophthalmic and Physiological Optics, 29, 472-476. https://doi.org/10.1111/j.1475-1313.2008.00617.x
[11]
Ampudia, J., Guardia, E., Castrillo, P., Cutillas, M., Soldevila, J. and de Leiva, A. (1993) Thyroid Ophthalmopathy: Clinical and Tomographic Study. Medicina Clínica, 100, 447-449.
Park, N., Moon, J. and Lee, J. (2019) Hertel Exophthalmometer versus Computed Tomography Scan in Proptosis Estimation in Thyroid-Associated Orbitopathy. Clinical Ophthalmology, 13, 1461-1467. https://doi.org/10.2147/OPTH.S216838
